Skip to main content
. 2024 Jan 29;12(2):138. doi: 10.3390/vaccines12020138

Figure 6.

Figure 6

High−performance liquid chromatograms of samples from the H5N1 HPAIV purification process with each peak corresponding to different stages of the process: (A) clarified viral suspension, (B) virus ultrafiltration concentrate, (C) virus purified by CaptoTM Core 700, and (D) purified product after the second purification step.